A few decades ago, this approach would not be understood by many. Do you use psychedelic drugs to treat people with PTSD? Depression? Addiction? To stop smoking? For maybe treating Alzheimer’s? Hewu. Just say no.
Were not these drugs the drugs we were told we were growing up to be? But times have penis envy mushrooms , and today, as in many other cultural shifts, people are again looking at some of the things that were considered inappropriate a short time ago.
And it is possible
- That the same generation
- That became famous for drugs
- Could benefit from
- Their healing power
Roland R. Griffiths, Ph.D., a psychologist and professor in the Department of Psychiatry and Behavioral Sciences and the Department of Neurological Sciences at Johns Hopkins University School of Medicine, said in an interview that this approach could offer a “completely new paradigm.” . ”
He should know
Griffiths started a psilocybin research program at Johns Hopkins nearly 20 years ago and led studies mushroom the effects of its use by healthy volunteers. His research team at Johns Hopkins was the first to receive regulatory approval in the US to restart research on psychedelics in healthy psychedelic-naïve volunteers in 2000.
Griffiths said his team’s 2006 publication in the journal Psychopharmacology on psilocybin was widely regarded as an important symbol. that sparked a revival of psychedelic research around the world.
Griffiths and his team have published a number of important lessons in peer-reviewed articles in more than 60 peer-reviewed science journals. In fact, Johns Hopkins scientists have given psilocybin to more than 350 healthy volunteers or patients over the past 19 years in about 700 sessions.
Griffiths will lead
A new Center for Psychological Research and Understanding at Johns Hopkins Medicine. The first of its kind in the U.S. and the largest research center of its kind in the world, the center was initially funded with a $ 17 million donation from a group of private donors to https://mungus.com the emerging sector of psychiatry and wellness.
- The center will consist of a team of six
- Neuroscientists, experimental psychologists and psychologists
- And five doctoral graduates
Graduate and doctoral students who want to work in the psychedelic science, but who have a few ways to study in this field, will be trained at this institute.
“We must take bold and courageous action if we are to help those suffering from chronic illness, addiction and penis envy mushrooms health challenges,” Alex Cohen, president of the Steven & Alexandra Cohen Foundation and fundraiser, said in a statement.
“By investing in the Johns Hopkins Institute, we are investing in the hope that researchers will continue to prove the benefits of psychedelics – and that people will have new therapies.”